Summary
GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of respiratory, cardiovascular, metabolic and urological diseases, immuno-inflammation and cancer, among others. The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders. Its vaccine portfolio cover various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company operates research facilities in France, Germany, the UK, Belgium, Spain, the US, Canada, and China. Its operations span Asia and the Middle East, Australasia, North America, South and Central America, and Europe. GSK is headquartered in Middlesex, the UK.
GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
GlaxoSmithKline Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
GlaxoSmithKline Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
GlaxoSmithKline Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
GlaxoSmithKline Plc, Medical Equipment, Deal Details 13
Venture Financing 13
Progyny Raises Additional Funds through Venture Financing 13
ZappRx Raises USD5.6 Million in Series A Financing 14
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 14
ZappRx Raises US$2 Million In Seed Financing 16
Health XL Raises Funds Through Venture Financing 17
HTG Molecular Diagnostics Raises US$7.5 Million In Series E Financing 17
SR One Plans To Invest In Biotechnology Company 18
IlluminOss Medical Raises US$28 Million In Series C Financing 19
Auxogyn Raises US$18 Million In Series B Financing 21
SpringLeaf Therapeutics Secures Additional US$4 Million In Series B Financing 22
High Throughput Genomics Secures US$0.5 Million In Second Closing Of Series D Venture Round 23
Partnerships 25
GlaxoSmithKline to Form Joint Venture with Verily Life Sciences 25
GlaxoSmithKline May Form Joint Venture with Qualcomm 26
Propeller Health Enters into R&D Agreement with GlaxoSmithKline 26
Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 27
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 28
Feinstein Institute For Medical Research Enters Into Research Agreement With GSK, University of Pennsylvania And MIT 29
AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen 30
KineMed Enters Into Co-Development Agreement With GlaxoSmithKline 31
Epistem Holdings Enters Into Co-Development Agreement With GlaxoSmithKline 32
Siemens Healthcare Diagnostics Enters Into Co-Development Agreement With ViiV Healthcare 33
Abbott Labs Expands Its Co-Development Agreement With GlaxoSmithKline Biologicals 34
Life Technologies Enters Into Co-Development Agreement With GlaxoSmithKline Biologicals 35
Enigma Diagnostics Enters Into Co-Development Agreement With GlaxoSmithKline 35
Imperial College London, King's College London, University College London, Medical Research Council And GSK Form Joint Venture 36
Insulet Enters Into Distribution Agreement With GlaxoSmithKline 38
Equity Offering 39
Response Genetics Completes Private Placement Of Shares For US$9 Million 39
Asset Transactions 40
Sinclair IS Pharma Acquires Atlean From Stiefel Labs 40
Acquisition 40
Teleflex Acquires Semprus BioSciences For Up To US$80 Million 40
GlaxoSmithKline Plc - Key Competitors 43
Key Employees 44
Locations And Subsidiaries 45
Head Office 45
Other Locations & Subsidiaries 45
Recent Developments 60
Strategy And Business Planning 60
Apr 18, 2016: GSK opens new state of the art respiratory manufacturing facility in Ware, UK 60
Apr 04, 2016: Heptares Joins Pharma Consortium Applying State of the Art Cryo-Electron Microscopy to Advance Structure Based Drug Discovery 61
Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund 62
Financial Announcements 63
Feb 08, 2017: GlaxoSmithKline: Results announcement for the fourth quarter 2016 63
Oct 26, 2016: GlaxoSmithKline: Results Announcement for the third quarter 2016 79
Jul 27, 2016: GlaxoSmithKline: Results announcement for the second quarter 2016 and half-yearly financial report for the half-year 2016 85
Apr 27, 2016: GSK Announces First quarter 2016 100
Feb 03, 2016: GSK Announces Full year and Fourth Quarter 2015 Results 104
Corporate Communications 106
Jan 19, 2017: Abbas Hussain to leave GSK 106
Jan 19, 2017: Luke Miels appointed President, Global Pharmaceuticals, GSK 107
Dec 19, 2016: GSK announces Board changes 108
Sep 29, 2016: GlaxoSmithKline appoints Brian McNamara as CEO of GSK Consumer Healthcare 109
Sep 20, 2016: Emma Walmsley to succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline 110
Jun 14, 2016: GlaxoSmithKline: Executive Director Change 111
May 27, 2016: GlaxoSmithKline Announces Board and Committee changes 112
Mar 17, 2016: Sir Andrew Witty to retire from GSK in March 2017 113
Mar 17, 2016: GlaxoSmithKline: Directorate changes 114
Legal and Regulatory 115
Jan 20, 2016: Scientists Indicted For Allegedly Stealing Biopharmaceutical Trade Secrets 115
Product News 116
03/07/2016: New Health Outcomes Data Reinforce Role of Device Selection and Peak Inspiratory Flow Rate in Treatment of COPD Patients 116
Other Significant Developments 117
Jul 27, 2016: GSK announces significant new investment in UK manufacturing network 117
Jul 07, 2016: GSK and Save the Children call for developing country innovations to enter $1 million award 118
Mar 31, 2016: GSK expands graduated approach to patents and intellectual property to widen access to medicines in the world’s poorest countries 119
Mar 04, 2016: GSK names winners of 2015 Discovery Fast Track Challenge 120
Appendix 121
Methodology 121
About GlobalData 121
Contact Us 121
Disclaimer 121
List of Tables
GlaxoSmithKline Plc, Medical Equipment, Key Facts, 2016 1
GlaxoSmithKline Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
GlaxoSmithKline Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
GlaxoSmithKline Plc, Deals By Market, 2011 to YTD 2017 9
GlaxoSmithKline Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Progyny Raises Additional Funds through Venture Financing 13
ZappRx Raises USD5.6 Million in Series A Financing 14
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 14
ZappRx Raises US$2 Million In Seed Financing 16
Health XL Raises Funds Through Venture Financing 17
HTG Molecular Diagnostics Raises US$7.5 Million In Series E Financing 17
SR One Plans To Invest In Biotechnology Company 18
IlluminOss Medical Raises US$28 Million In Series C Financing 19
Auxogyn Raises US$18 Million In Series B Financing 21
SpringLeaf Therapeutics Secures Additional US$4 Million In Series B Financing 22
High Throughput Genomics Secures US$0.5 Million In Second Closing Of Series D Venture Round 23
GlaxoSmithKline to Form Joint Venture with Verily Life Sciences 25
GlaxoSmithKline May Form Joint Venture with Qualcomm 26
Propeller Health Enters into R&D Agreement with GlaxoSmithKline 26
Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 27
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 28
Feinstein Institute For Medical Research Enters Into Research Agreement With GSK, University of Pennsylvania And MIT 29
AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen 30
KineMed Enters Into Co-Development Agreement With GlaxoSmithKline 31
Epistem Holdings Enters Into Co-Development Agreement With GlaxoSmithKline 32
Siemens Healthcare Diagnostics Enters Into Co-Development Agreement With ViiV Healthcare 33
Abbott Labs Expands Its Co-Development Agreement With GlaxoSmithKline Biologicals 34
Life Technologies Enters Into Co-Development Agreement With GlaxoSmithKline Biologicals 35
Enigma Diagnostics Enters Into Co-Development Agreement With GlaxoSmithKline 35
Imperial College London, King's College London, University College London, Medical Research Council And GSK Form Joint Venture 36
Insulet Enters Into Distribution Agreement With GlaxoSmithKline 38
Response Genetics Completes Private Placement Of Shares For US$9 Million 39
Sinclair IS Pharma Acquires Atlean From Stiefel Labs 40
Teleflex Acquires Semprus BioSciences For Up To US$80 Million 40
GlaxoSmithKline Plc, Key Competitors 43
GlaxoSmithKline Plc, Key Employees 44
GlaxoSmithKline Plc, Other Locations 45
GlaxoSmithKline Plc, Subsidiaries 45
List of Figures
GlaxoSmithKline Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
GlaxoSmithKline Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
GlaxoSmithKline Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
GlaxoSmithKline Plc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
